paul’s slides for george -- to put in imaging core for adrc eab meeting
DESCRIPTION
Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/1.jpg)
Paul’s Slides for George --to put in IMAGING CORE for
ADRC EAB meeting
![Page 2: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/2.jpg)
Summary
We developed 4 major new methods to track brain change, e.g. Alzheimer’s disease or MCI
progression
Can now map disease spreading in the living brain (cortical thickness video maps,
fluid maps of brain change - TBM)
Feasible to map subtle brain changes (~0.5% volume loss) in an individual over 2-4 weeks
Now testing in large trials to distinguish drug effects (galantamine, lithium, antipsychotics)
![Page 3: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/3.jpg)
![Page 4: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/4.jpg)
Cortical Thickness Mapping (used in ~30 papers)- see Thompson et al., 2004 (for an overview)
![Page 5: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/5.jpg)
Example: AIDS Dementia Complex (Thompson et al., Proc. Nat. Acad. Sci., 2005)
![Page 6: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/6.jpg)
Also began to correlate cortical thickness on MRwith FDG-PET in healthy controls and AD (Thompson/Huang/Small)
![Page 7: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/7.jpg)
Who did we train to use our tools?
• Univ. of Pittsburgh ADC (PI: Oscar Lopez) began to use our HP/CTX methods and have submitted ~10 papers on MCI and AD (N=381), HIV-associated dementia (N=53), and semantic dementia. One was in PNAS this month (Thompson et al., 2005)
• Liana Apostolova MD, ADRC, Asst. Prof. (journal papers submitted on cortical thinning in MCI, relation to apathy, hippocampal atrophy in MCI, several in preparation)
• Giovanni Frisoni, Rome, Italy -- submitted several papers using our hippocampal/cortex mapping methods
• Mony de Leon, NYU (learning surface-based PET analysis)• Addition of large longitudinal datasets (G. Bartzokis), presenilin subjects (J.
Ringman), ADNI (M. Weiner/C. Jack - analysis of 200 prep phase scans is now submitted to NeuroImage; not ADRC but further validated methods)
• Began PET-MRI work correlating MRI thickness with FDG-PET in G. Small’s ApoE genotyped normals (N=30 approx., to date; also FDDNP, MPPF; N=6-10; data will be submitted to HBM, Dec 05)
![Page 8: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/8.jpg)
Large-scale automated 3D ventricular mapping in elderly controls, MCI, AD
(N=381; Thompson/UCLA/U. Pittsburgh)
![Page 9: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/9.jpg)
How Can We Best Track Neurodegenerative BrainChange in an Individual?
![Page 10: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/10.jpg)
Thompson et al., Nature 404:190-193 (2000).
![Page 11: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/11.jpg)
![Page 12: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/12.jpg)
Case Study: Mapping Atrophy in a Semantic Dementia PatientThompson/Glaxo study
![Page 13: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/13.jpg)
Changes Internal to the Basal Gangliain a Semantic Dementia Patient (Case Study)
![Page 14: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/14.jpg)
Automated Mappingof
Trajectory of WM Atrophy over time
in a Patient with progressive posterior cortical atrophy and Broca’s area atrophy
(Case Study; P. Thompson et al./U. Queensland/Glaxo)
Promising Biomarker for Trials
![Page 15: Paul’s Slides for George -- to put in IMAGING CORE for ADRC EAB meeting](https://reader035.vdocuments.mx/reader035/viewer/2022062423/568149bb550346895db6f0b5/html5/thumbnails/15.jpg)
Summary
New methods to track brain change, e.g. Alzheimer’s disease progression
Can now map disease spreading in the living
brain (cortical thickness video maps, fluid maps of brain change)
Now testing in large trials to distinguish drug effects (galantamine, lithium, antipsychotics)
Feasible to map subtle brain changes (~0.5% volume loss) in an individual over 2-4 weeks